ArriVent BioPharma(AVBP) - 2024 Q1 - Quarterly Results

Exhibit 99.1 ArriVent BioPharma Reports First Quarter 2024 Financial Results NEWTOWN SQUARE, PA, May 8, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. ("Company" or "ArriVent") (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the first quarter ended March 31, 2024, and highlighted recent Company progress. "In the first quarter of this year, we continued our strong progress as we ful ...